CD14 and Sepsis: Our findings are limited by missing data about levels of PDE4 (or PDE4 activity) in CD14+ monocytes from control subjects and patients with sepsis; these data would strengthen the conclusion that inhibition of PDE4 activity is a potential treatment for sepsis.